Clinical Trial Update: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 2/Phase 3 study evaluating radiofrequency ablation combined with cytokine-induced killer cells for cholangiocarcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Cytokine-induced killer cells
• Radiofrequency ablation (radiofrequency energy)

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Cholangiocarcinoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING